PARALLEL BIO Trademark

Trademark Overview

On Monday, December 6, 2021, a trademark application was filed for PARALLEL BIO with the United States Patent and Trademark Office. The USPTO has given the PARALLEL BIO trademark a serial number of 97157902. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, June 11, 2024. This trademark is owned by Parallel Biosystems, Inc.. The PARALLEL BIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biologic preparations for use in oncology, immunology, and cell degeneration; Pharmaceutical preparations, namely, therapeutic agents, immunotherapies, antibody therapies, and cell therapies for the treatment of cancer, autoimmune diseases, degenerative diseases; Vaccines; Antibodies for medical and medical diagnostic laboratory use
parallel bio

General Information

Serial Number97157902
Word MarkPARALLEL BIO
Filing DateMonday, December 6, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, June 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements

Goods and ServicesPharmaceutical and biologic preparations for use in oncology, immunology, and cell degeneration; Pharmaceutical preparations, namely, therapeutic agents, immunotherapies, antibody therapies, and cell therapies for the treatment of cancer, autoimmune diseases, degenerative diseases; Vaccines; Antibodies for medical and medical diagnostic laboratory use
NOT AVAILABLE"BIO"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameParallel Biosystems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameParallel Biosystems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTorrance, CA 90502

Trademark Events

Event DateEvent Description
Thursday, December 9, 2021NEW APPLICATION ENTERED
Friday, December 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 14, 2022ASSIGNED TO EXAMINER
Monday, September 19, 2022NON-FINAL ACTION WRITTEN
Monday, September 19, 2022NON-FINAL ACTION E-MAILED
Monday, September 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 20, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 20, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, September 20, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 20, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, September 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 5, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, May 5, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 5, 2023SOU EXTENSION 1 FILED
Friday, May 5, 2023DIVISIONAL REQUEST RECEIVED
Tuesday, May 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 2, 2023DIVISIONAL PROCESSING COMPLETE
Friday, June 2, 2023SOU EXTENSION 1 GRANTED
Saturday, June 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 3, 2023CORRECTED NOA E-MAILED
Tuesday, June 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU EXTENSION 3 GRANTED
Wednesday, June 12, 2024SOU EXTENSION 3 FILED
Tuesday, December 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 10, 2023SOU TEAS EXTENSION RECEIVED
Sunday, December 10, 2023SOU EXTENSION 2 FILED
Sunday, December 10, 2023SOU EXTENSION 2 GRANTED

Related Keywords

parallel cell diseases medical pharmaceutical therapies preparations degenerative autoimmune antibodies laboratory